The University of Chicago Header Logo

Connection

Michael Becker to Histone Deacetylase Inhibitors

This is a "connection" page, showing publications Michael Becker has written about Histone Deacetylase Inhibitors.
  1. Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemia. Mol Cancer Ther. 2014 Aug; 13(8):1979-90.
    View in: PubMed
    Score: 0.113
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.